Comparison of GnRH agonists and antagonists the outcome IVF/ICSI in women with polycystic ovary syndrome
Phase 2
- Conditions
- Polycystic ovarian syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT201402041760N30
- Lead Sponsor
- Vice Chancellor for Research and Technology, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
PCOs; having two of the three diagnostic criteria Rotterdam 2003(Irregular menstruation oligomenorrhea, amenorrhea and irregular bleeding); hyperandrogenism(Hirsutism, severe acne, hair loss); obesity; polycystic ovaries on ultrasound to rule out specific diseases such as disorders of the hypothalamus, pituitary or other causes hyperandrogenism ; age = 35 years; FSH <12 mlu / ml on days 2-3 of the cycle
Exclusion criteria: history of more than two abortions;
in laparoscopic uterine anomaly, hysteroscopy & hysterosonography; ovarian cysts.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pregnancy. Timepoint: 7-6 weeks to see the gestational sac. Method of measurement: Ultrasound.
- Secondary Outcome Measures
Name Time Method Duration of ovarian stimulation. Timepoint: Duration of drug use. Method of measurement: Clinical.;Number of drugs. Timepoint: Duration of treatment. Method of measurement: clinical.;The cost. Timepoint: Time to confirm pregnancy. Method of measurement: Amount spent.